Similar articles

• Stopping a trial early in oncology: for patients or for industry?

  Whitehead J, Cobo E. Whitehead J, et al. Ann Oncol. 2008 Aug;19(8):1512-1513. doi: 10.1093/annonc/mdn410. Epub 2008 Jul 10. Ann Oncol. 2008. PMID: 18621741 No abstract available.
• Stopping a trial early in oncology: for patients or for industry?

  Trotta F, Apolone G, Garattini S, Tafuri G. Trotta F, et al. Ann Oncol. 2008 Jul;19(7):1347-1353. doi: 10.1093/annonc/mdn042. Epub 2008 Feb 27. Ann Oncol. 2008. PMID: 18304961
• Data Monitoring Committees and early stopping guidelines: the Southwest Oncology Group experience.

  Crowley J, Green S, Liu PY, Wolf M. Crowley J, et al. Stat Med. 1994 Jul 15-30;13(13-14):1391-9. doi: 10.1002/sim.4780131314. Stat Med. 1994. PMID: 7973218
• Clinical significance in pediatric oncology randomized controlled treatment trials: a systematic review.

  Howard AF, Goddard K, Rassekh SR, Samargandi OA, Hasan H. Howard AF, et al. Trials. 2018 Oct 5;19(1):539. doi: 10.1186/s13063-018-2925-8. Trials. 2018. PMID: 30290839 Free PMC article.
• [Health related quality of life and endpoints in oncology].

  Bonnetain F. Bonnetain F. Cancer Radiother. 2010 Oct;14(6-7):515-8. doi: 10.1016/j.canrad.2010.06.001. Epub 2010 Jul 31. Cancer Radiother. 2010. PMID: 20674446 Review. French.